ShiraTronics, a medical device company developing neurostimulation therapies for chronic migraine patients, has closed a $66 million Series B financing round. The investment…

Triveni Bio Inc., a cutting-edge biotech company developing novel antibody treatments for immune and inflammatory (I&I) disorders, announced the successful closure of a…

Nym, a pioneer in autonomous medical coding, has announced a $47 million growth investment led by PSG, with participation from Google Ventures, Addition,…

C2N Diagnostics, a leader in developing Alzheimer’s disease-specific fluid biomarker tests, has announced a $15 million program-related investment from GHR Foundation to enhance…

858 Therapeutics has secured $50 million in a Series B funding round led by Avidity Partners, with participation from Insight Partners, Mirae Asset…